Even though several women have accused porn star James Deen of rape and assault, his career is thriving, according to a new study.
Vocativ has found that fans are searching for his scenes just as much as before, and studios are releasing just as many of Deen’s movies.
When Deen’s ex-girlfriend Stoya accused him of rape on Twitter in November and many other alleged victims followed, searches for the porn actor “more than tripled from the month before, leaping from 338 to 1,083 searches” on xHamster, a major porn website.
In January, the number dropped to 559 searches, and in February it dropped back down into the 300 range.
According to Vocativ, in the 100 days before the first allegation, 38 films featuring Deen were released. In the 100 days after, 45 films were released.
Deen’s rep, Howard Bragman, told Vocativ that Deen is getting just as many gigs with other studios as he did before all the allegations.
“James is continuing to perform in scenes for other companies the same amount as he was before,” he said. Bragman has not yet responded to TheWrap’s request for comment.
The adult film star and producer was accused of assault by nine women. Three of those accusers said the alleged assaults took place on the set of a porn film: Tori Lux, who claimed that Deen attacked her on a shoot in 2011; Amber Rayne, who claimed Deen punched her twice in the face and “brutally” sodomized her during a 2006 shoot; and Kora Peters, who said Deen ignored her refusal to perform anal sex and did so forcibly, after which the crew “all high-fived him.”
On March 9, legal documents obtained by TheWrap showed Deen’s porn company is facing fines up to $77,875 for violating workplace safety regulations, including the failure to use condoms on set.
Investigators at Cal/OSHA (California Department of Industrial Relations Division of Occupational Safety and Health) found that Third Rock Enterprises, also known as James Deen Productions, “failed to make the hepatitis B vaccine and vaccination series [available] to all employees who have had occupational exposure and to make available a post-exposure evaluation and follow-up for bloodborne pathogens exposure to all employees who have had an exposure incident.”
See Vocativ‘s chart of the study below.
